|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Moore's Prescription Insures Socialized Medicine Misery; 'Sicko' ignores U.S. strengths and national care's faults
Tanner, a senior fellow at the Cato Insitute, writes that Michael Moore's soon to be released indictment of American health care, Sicko, ignores the strengths of free–market medicine while understating the problems of single–payor health care.
Eighteen of the last 25 winners of the Nobel Prize in Medicine are U.S. citizens or work here. With no price controls, free–market U.S. medicine provides the incentives that lead to innovative breakthroughs in drugs and other medical technologies. U.S. companies have developed half of all the major new medicines introduced worldwide during the past 20 years. In fact, Americans played a key role in 80 percent of the most important medical advances of the past 30 years.
|home spotlight commentary research events news about contact links archives|